JPRN-UMIN000014207已完成2 期
Efficacy and safety of ninjinyoeito, Japanese Kampo medicine, on peripheral neuropathy and anemia induced by oxaliplatin - HOPE-2
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Prior blood transfusion or G-CSF administration 2. Severe drug hypersensitivity 3. Peripheral neuropathy due to diabetes mellitus etc. 4. diabetes mellitus requiring insulin therapy
研究者
相似试验
招募中
不适用
Clinical investigation of ninjin'yoeito on the recovery phase of inpatients with acute illness.Inpatients with acute illnessJPRN-UMIN000035979Japanese Red Cross Kumamoto Hospital80
已完成
不适用
Efficacy and Safety of Nintedanib in Japanese patients with early stage of idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosis (IPF)JPRN-UMIN000038192Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences215
招募中
不适用
A Study of the Efficacy of Ninjin'yoeito in Patients with Pulmonary Non-tuberculous Mycobacterial InfectioPulmonary non-tuberculousis mycobacteriaJPRN-UMIN000047951Shizuoka General Hospital80
尚未招募
不适用
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (modified MAID therapy) for high grade bone and soft tissue sarcomas.High-grade bone and soft tissue sarcomasJPRN-UMIN000015113Tokyo Metropolitan Komagome Hospital10
尚未招募
不适用
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (GD therapy) for high-grade soft tissue sarcomas.High-grade soft tissue sarcomasJPRN-UMIN000015120Tokyo Metropolitan Komagome Hospital10